Skip to main content
Equibles

STOREBRAND ASSET MANAGEMENT AS

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1685676 LYSAKER, Q8
Back to UTHR Full portfolio

Position in UTHR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$49,680,392
-$5,907,332 QoQ
Shares Held
91,690
-2.2% QoQ
Ownership
0.214%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#71
of 870 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

STOREBRAND ASSET MANAGEMENT AS holds $68,472,125 across 4 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (72.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
This page 		91,690 $49,680,392
2 VTRS
Viatris Inc
 685,858 $10,891,425
3 ZTS
Zoetis Inc.
 93,356 $6,708,562
4 NBIX
Neurocrine Biosciences Inc
 7,071 $1,191,746

All Filings in UTHR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $49,680,392 91,690
2026-03-31 $55,587,724 93,743
2025-12-31 $45,705,999 93,804
2025-09-30 $34,686,273 82,742
2025-06-30 $26,316,375 91,583
2025-03-31 $29,158,026 94,586
2024-12-31 $33,716,684 95,558
2024-09-30 $35,539,361 99,175
2024-06-30 $35,858,854 112,569
2024-03-31 $25,762,179 112,146
2023-12-31 $25,100,223 114,149
2023-09-30 $26,024,515 115,219
2023-06-30 $26,093,312 118,203
2023-03-31 $27,305,651 121,922
2022-12-31 $34,881,662 125,433
2022-09-30 $26,263,161 125,433
2022-06-30 $24,856,014 105,483
2022-03-31 $18,924,705 105,483
2021-12-31 $23,332,966 107,983
2021-09-30 $19,723,849 106,858
2021-06-30 $19,199,202 107,013
2021-03-31 $18,314,225 109,489
2020-12-31 $15,515,822 102,219
2020-09-30 $10,117,271 100,171
2020-06-30 $12,198,736 100,816
2020-03-31 $10,124,050 106,760

Report a Problem

Category
Description
Email (optional, for follow-up)